High frequency of known copy number abnormalities and maternal duplication 15q11-q13 in patients with combined schizophrenia and epilepsy

Stewart, Larissa R; Hall, April L; Kang, Sung-Hae L; Shaw, Chad A; Beaudet, Arthur L

doi:10.1186/1471-2350-12-154

Table 3 CNVs of unknown significance in schizophrenia and epilepsy samples

From: High frequency of known copy number abnormalities and maternal duplication 15q11-q13 in patients with combined schizophrenia and epilepsy

NIMH ID	Sex	Chr.	Start	Size (bp)		Genes	Validation	DGV
142-1320-001	M	2p21	44531130	68210	Loss	SLC3A1, PREPL, C3orf34	Cus1	2 overlap
149-1129-001	F	2p16.1	56091146	13954	Gain	EFEMP1	Cus4	None
49-1020-001^a	F	4q28.2	129774971	154534	Gain	PHF17, SCLT1	Cus4	Identical
53-10259	F	6p22.3	17465076	387198	Gain	4	Cus4	1 overlap
70-11763	F	6p22.3	22272906	148050	Loss	PRL	Cus4	1 overlap
144-1291-001	M	6q14.1	76607923	25447	Loss	MYO6, IMPG1	Cus1	None
54-10078	F	6q15	87456408	730692	Gain	9	Cus4	3 overlap
144-1096-001	M	7q11.22	71029067	240023	Gain	WBSCR17, CALN1	Cat	Identical
142-1006-001	F	7q31.32	122364506	676522	Gain	CADPS2, TAS2R16, SLC13A1	Cus4	5 overlap
149-1114-001	M	8q21	84569675	844484	Loss	RALYL	Cat	1 overlap
54-10151^a	M	9p24.3	115980	471438	Loss	5	Cat	Common
141-0680-001	F	9p24.1	6451073	394797	Gain	UHRF2, GLDC, KDM4C	Cus4	4 overlap
142-1340-001	M	12p13.33	1949926	37541	Loss	CACNA2D4	Cus1	1 overlap
143-2467-001	M	12p13.33	1949882	34631	Loss	CACNA2D4	Cus1	1 overlap
146-2019-001	M	12p11.22	29009447	562052	Gain	FAR2, ERGIC2	Cat	1 overlap
142-1274-001	M	13q34	110957062	275718	Gain	COL4A2, RAB20	Cus4	1 overlap
140-2154-001	M	13q34	114476840	148441	Gain	FLJ44054, GAS6, FAM70B	Cus4	2 overlap
144-1307-001	M	15q11.2	22842143	244550	Gain	TUBGCP5, CYFIP1, NIPA2,NIPA1 ^b	MLPA	Common
147-2423-001	M	15q13.3	32296138	142658	Gain	CHRNA7 ^b	MLPA	Common
35-71412-02	M	15q13.3	32296138	164344	Gain	CHRNA7 ^b	MLPA	Common
42-1051-002	F	16p13.2	8969708	103443	Gain	USP7	Cat	1 overlap
143-2384-001	M	16p13.2	8581817	830333	Gain	9	Cat	1 overlap
147-2080-001	M	16p13.12	12771677	165576	Loss	CPPED1	Cat	2 overlap
54-10151^a	M	17p13.3	2995336	422668	Gain	14	Cat	1 overlap
54-10151^a	M	17p13.2	3743015	483613	Gain	8^b	Cat	2 overlap
49-1020-001^a	F	17p12	14111831	1330176	Gain	9	Cat	Identical
142-1278-001	M	17p12	14897946	148020	Loss	CDRT7	Cus4	Identical
144-1594-001	M	17p11.2	21311601	50888	Gain	KCNJ12 ^b	Cus3	Identical
148-2171-001	M	17q11.2	28524944	21111	Gain	SLC6A4	Cus1	None
35-08447-02	M	18q11-q12	24744073	458607	Gain	CHST9	Cus4	None
30-11632	F	19p13.3	6427852	429890	Gain	14	Cus4	None
143-2526-001	M	19q13.42	54646013	1707820	Gain	87	Cat	7 overlap

Abbreviations: As in Table 1.
^a denotes samples having more than one CNV.
^b denotes cases which had a similar call to CNV found in controls.

Back to article page

ISSN: 1471-2350

Contact us

General enquiries: ORSupport@springernature.com

BMC Medical Genetics

Contact us